Generic placeholder image

Mini-Reviews in Medicinal Chemistry


ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

General Review Article

Janus Kinase Inhibitors: A Review of Their Application in the Vitiligo

Author(s): Chao Niu , Hunjun Xie and Haji Akber Aisa *

Volume 21, Issue 20, 2021

Published on: 25 March, 2021

Page: [3203 - 3218] Pages: 16

DOI: 10.2174/1389557521666210325120233

Price: $65


Abstract: The small-molecular inhibitors targeted JAks (JAK inhibitors) could modulate the cytokines- mediated signaling via the JAK-STAT pathway, which plays an important role in immune regulation and cell proliferation. The JAK inhibitors were previously designed and synthesized to treat diseases involving the hematologic and immune system. Increasing evidence shows that they are quite effective in Atopic Dermatitis (AD), Alopecia Areata (AA), psoriasis, vitiligo, and other autoimmuneinduced dermatologic conditions. Currently, many JAK inhibitors possessing anti-vitiligo activity are being investigated in the laboratory and clinically. In this view, we would like to summarize the applications of these inhibitors with emphasis on the profile of vitiligo, clinical efficacy, dosages, development of new candidates and adverse events through available literature.

Keywords: JAK-STAT, JAK inhibitors, dermatologic conditions, vitiligo, tofacitinib, ruxolitinib.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy